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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Podocyte-specific 
overexpression of 
human angiotensin-
converting enzyme 2 
attenuates diabetic 
nephropathy in mice
Angiotensin-converting enzyme 2 (ACE2) 
is a recently discovered protease that is 
homologous to ACE1. However, instead 
of generating angiotensin II, it cleaves 
angiotensin II to angiotensin-(1–7). ACE2 
is expressed in podocytes, but its biologic 
role remains poorly defined. Nadarajah 
and colleagues created transgenic mice 
that overexpress ACE2 in podocytes. They 
report that after treatment with strepto-
zotocin to induce diabetes, these mice 
had delayed onset of albuminuria and 
developed less severe histologic kidney 
disease after 16 weeks. This study demon-
strates that increased ACE2 expression in 
podocytes can delay onset of experimental 
diabetic nephropathy, raising the possibil-
ity that efforts to increase ACE2 expression 
may be a viable strategy to prevent or treat 
diabetic kidney disease. See page 292.
Moderation of 
dietary sodium 
potentiates the renal 
and cardiovascular 
protective effects of 
angiotensin receptor 
blockers
The role of dietary sodium restriction in 
improving clinical outcomes has been the 
subject of much recent controversy. In this 
issue, Lambers Heerspink et al. report the 
results of a post hoc analysis of the Reduc-
tion of End Points in noninsulin-dependent 
diabetes mellitus with the Angiotensin II 
Receptor Antagonist Losartan (RENAAL) 
trial and the Irbesartan Diabetic Nephropa-
thy Trial (IDNT) in which they examine the 
relationship between dietary sodium (meas-
ured as 24-hour urinary sodium/creatinine 
ratio) and cardiovascular and renal outcomes 
in patients with diabetic nephropathy. They 
found that patients randomized to angio-
tensin receptor blocker treatment who had 
lower sodium intake had fewer renal and 
cardiovascular events. These results suggest 
that sodium restriction may be an important 
strategy to improve outcomes in patients 
with diabetic nephropathy. See page 330.
Endothelial injury 
in transplant 
glomerulopathy 
is correlated with 
transcription factor 
T-bet expression
Transplant glomerulopathy (TG) is an 
important cause of kidney allograft failure. 
Previous studies have implicated a role for 
inflammatory endothelial-cell injury in 
TG, but the pathogenesis remains unclear. 
T-bet is a T-box transcription factor that 
promotes development of Th1 cells and 
production of interferon-g. Sun et al. stud-
ied the role of T-bet in endothelial injury in 
TG. They found that T-bet expression was 
increased in glomerular and peritubular 
capillaries in TG biopsies and that areas 
of elevated T-bet expression had increased 
infiltration by CD4+, CD8+, and CD68+ 
cells. Moreover, infiltration by CD68+ cells 
was associated with abnormal microvascu-
lar morphology. T-bet may therefore be an 
important mediator of immune activation 
that promotes the endothelial injury found 
in TG. See page 321.
